This is a routine, tax-motivated sale from restricted stock vesting with no trading implications. Monitor for any larger insider dispositions or changes in senior leadership selling patterns, but this filing alone does not warrant a trade action.
Price Chart
Executive Summary
Director Roger Jeffs filed a Form 144 to sell 286 shares of Axsome Therapeutics common stock, valued at approximately $70,407. The shares originated from a restricted stock lapse on June 6, 2026, and the sale appears to be a routine tax-withholding transaction. The dollar amount is negligible relative to the company's $12.7B market cap, making this filing inconsequential for traders.
Key Facts
- Director Roger Jeffs filed Form 144 to sell 286 shares of common stock.
- Estimated sale value of $70,407 based on June 10, 2026 trade.
- Shares originated from a restricted stock lapse (equity compensation) on June 6, 2026.
- Sale constitutes a trivial fraction of the company's $12.7B market capitalization.
- No indication of a Rule 10b5-1 trading plan (filing marked as 'LIVE'), but size and context suggest routine tax-motivated sale.
Financial Impact
Sale of 286 shares for ~$70,407, representing ~0.0006% of AXSM's market cap.
Risk Factors
- None material — extremely small relative to market cap.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001921094-26-000636 |
| Document: 0001921094-26-000636-index.html | 0001921094-26-000636 |
| Document: 0001921094-26-000636.txt | 0001921094-26-000636 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 11, 2026 7w ago | Institutional Cluster | $214.66 $211.12 | ▼ −1.65% | ▲ +0.25% | $179.25 (−16.50%) |
Aug 10, 2026 7w ago | 8-K | $220.89 $207.82 | ▼ −5.92% | ▼ −5.00% | $179.25 (−18.85%) |
Aug 10, 2026 7w ago | Press Release | $220.89 $207.82 | ▼ −5.92% | ▼ −5.00% | $179.25 (−18.85%) |
Jul 15, 2026 11w ago | Press Release | $237.53 $214.66 | ▼ −9.63% | ▼ −11.97% | $179.25 (−24.54%) |
Jul 9, 2026 12w ago | Court Ruling | $248.95 $210.13 | ▼ −15.59% | ▼ −17.84% | $179.25 (−28.00%) |
Jul 7, 2026 12w ago | Press Release | $249.76 $211.04 | ▼ −15.50% | ▼ −16.84% | $179.25 (−28.23%) |
Jul 1, 2026 13w ago | 144 | $244.31 $234.64 | ▼ −3.96% | ▼ −3.54% | $179.25 (−26.63%) |
Jun 15, 2026 15w ago | Press Release | $253.40 $228.28 | ▼ −9.91% | ▼ −9.16% | $179.25 (−29.26%) |
Jun 12, 2026 16w ago | Insider Cluster | $255.17 $233.80 | ▼ −8.37% | ▼ −10.15% | $179.25 (−29.75%) |
Jun 11, 2026 16w ago | 144 | $255.17 $233.80 | ▼ −8.37% | ▼ −10.15% | $179.25 (−29.75%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access